{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"description":"Adrenal insufficiency was defined by a 30 or 60 min cortisol \\< 18 during a cosyntropin stimulation test","groups":[{"description":"Receives intravenous hydrocortisone 100mg and following surgery intravenous dexamethasone 0.5mg\n\nhydrocortisone: 100mg at the time of surgery\n\ndexamethasone: 0.5mg every 6 hours for a total of four doses","id":"OG000","title":"Steroid Treatment Arm"},{"description":"Subjects will not receive any steroids at the time of surgery or after surgery unless symptoms of adrenal insufficiency develop (i.e. nausea, vomiting, dizziness, or low blood pressure).","id":"OG001","title":"Non-steroid Treatment"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"6 weeks following surgery","title":"Number of Participants With Adrenal Insufficiency","type":"PRIMARY","unitOfMeasure":"Participants"}